BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27821628)

  • 1. Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis.
    Jones BE; Yang J; Muthigi A; Hogan SL; Hu Y; Starmer J; Henderson CD; Poulton CJ; Brant EJ; Pendergraft WF; Jennette JC; Falk RJ; Ciavatta DJ
    J Am Soc Nephrol; 2017 Apr; 28(4):1175-1187. PubMed ID: 27821628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Yang J; Ge H; Poulton CJ; Hogan SL; Hu Y; Jones BE; Henderson CD; McInnis EA; Pendergraft WF; Jennette JC; Falk RJ; Ciavatta DJ
    Clin Epigenetics; 2016; 8():85. PubMed ID: 27752292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis.
    Ciavatta DJ; Yang J; Preston GA; Badhwar AK; Xiao H; Hewins P; Nester CM; Pendergraft WF; Magnuson TR; Jennette JC; Falk RJ
    J Clin Invest; 2010 Sep; 120(9):3209-19. PubMed ID: 20714105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of autoantigen genes in ANCA-associated vasculitis involves alternative transcripts and new protein synthesis.
    McInnis EA; Badhwar AK; Muthigi A; Lardinois OM; Allred SC; Yang J; Free ME; Jennette JC; Preston GA; Falk RJ; Ciavatta DJ
    J Am Soc Nephrol; 2015 Feb; 26(2):390-9. PubMed ID: 25060059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANCA autoantigen gene expression highlights neutrophil heterogeneity where expression in normal-density neutrophils correlates with ANCA-induced activation.
    Jones BE; Herrera CA; Agosto-Burgos C; Starmer J; Bass WA; Poulton CJ; Blazek L; Henderson CD; Hu Y; Hogan SL; Hu P; Xiao H; Wu EY; Chen DP; Jennette JC; Free ME; Falk RJ; Ciavatta DJ
    Kidney Int; 2020 Sep; 98(3):744-757. PubMed ID: 32446935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA disease.
    Chen DP; Aiello CP; McCoy D; Stamey T; Yang J; Hogan SL; Hu Y; Derebail VK; Wu EY; Jennette JC; Falk RJ; Ciavatta DJ
    JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36626226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent pathogenetic advances in ANCA-associated vasculitis.
    Pendergraft WF; Nachman PH
    Presse Med; 2015 Jun; 44(6 Pt 2):e223-9. PubMed ID: 26033562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological Interaction of HLA-DPB1 and Proteinase 3 in ANCA Vasculitis is Associated with Clinical Disease Activity.
    Chen DP; McInnis EA; Wu EY; Stember KG; Hogan SL; Hu Y; Henderson CD; Blazek LN; Mallal S; Karosiene E; Peters B; Sidney J; James EA; Kwok WW; Jennette JC; Ciavatta DJ; Falk RJ; Free ME
    J Am Soc Nephrol; 2022 Aug; 33(8):1517-1527. PubMed ID: 35672132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphism.
    Casal Moura M; Deng Z; Brooks SR; Tew W; Fervenza FC; Kallenberg CGM; Langford CA; Merkel PA; Monach PA; Seo P; Spiera RF; St Clair EW; Stone JH; Prunotto M; Grayson PC; Specks U
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36990659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
    Sanders JS; de Joode AA; DeSevaux RG; Broekroelofs J; Voskuyl AE; van Paassen P; Kallenberg CG; Tervaert JW; Stegeman CA
    Nephrol Dial Transplant; 2016 Sep; 31(9):1453-9. PubMed ID: 27242368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in relapse-rate and clinical phenotype by autoantibody-subtype in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Murosaki T; Sato T; Akiyama Y; Nagatani K; Minota S
    Mod Rheumatol; 2017 Jan; 27(1):95-101. PubMed ID: 27320904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics and complementary proteins.
    Ciavatta D; Falk RJ
    Clin Exp Immunol; 2011 May; 164 Suppl 1(Suppl 1):17-9. PubMed ID: 21447125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of vascular damage in ANCA vasculitis.
    Massicotte-Azarniouch D; Herrera CA; Jennette JC; Falk RJ; Free ME
    Semin Immunopathol; 2022 May; 44(3):325-345. PubMed ID: 35254509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A myelopoiesis gene signature during remission in anti-neutrophil cytoplasm antibody-associated vasculitis does not predict relapses but seems to reflect ongoing prednisolone therapy.
    Kurz T; Weiner M; Skoglund C; Basnet S; Eriksson P; Segelmark M
    Clin Exp Immunol; 2014 Feb; 175(2):215-26. PubMed ID: 24215168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
    Merkel PA; Xie G; Monach PA; Ji X; Ciavatta DJ; Byun J; Pinder BD; Zhao A; Zhang J; Tadesse Y; Qian D; Weirauch M; Nair R; Tsoi A; Pagnoux C; Carette S; Chung S; Cuthbertson D; Davis JC; Dellaripa PF; Forbess L; Gewurz-Singer O; Hoffman GS; Khalidi N; Koening C; Langford CA; Mahr AD; McAlear C; Moreland L; Seo EP; Specks U; Spiera RF; Sreih A; St Clair EW; Stone JH; Ytterberg SR; Elder JT; Qu J; Ochi T; Hirano N; Edberg JC; Falk RJ; Amos CI; Siminovitch KA;
    Arthritis Rheumatol; 2017 May; 69(5):1054-1066. PubMed ID: 28029757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Harper L; Cockwell P; Adu D; Savage CO
    Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from a double-transgenic neutrophil approach to induce antiproteinase 3 antibody-mediated vasculitis in mice.
    Schreiber A; Eulenberg-Gustavus C; Bergmann A; Jerke U; Kettritz R
    J Leukoc Biol; 2016 Dec; 100(6):1443-1452. PubMed ID: 27365530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis.
    Han WK; Choi HK; Roth RM; McCluskey RT; Niles JL
    Kidney Int; 2003 Mar; 63(3):1079-85. PubMed ID: 12631091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.
    Córdova-Sánchez BM; Mejía-Vilet JM; Morales-Buenrostro LE; Loyola-Rodríguez G; Uribe-Uribe NO; Correa-Rotter R
    Clin Rheumatol; 2016 Jul; 35(7):1805-16. PubMed ID: 26852317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.